Jan 24, 2024
MicroGen Diagnostics in Chronic Wounds

“Explore the fascinating realm of microbiology and healthcare in the MicroGenDX Mic’d Up podcast, hosted by Rick Martin, CEO of MicroGenDX. Join Rick and his special guest, the esteemed Caroline Fife, MD, FAAFP, CWS, Professor of Medicine at Baylor College of Medicine

“Explore the fascinating realm of microbiology and healthcare in the MicroGenDX Mic’d Up podcast, hosted by Rick Martin, CEO of MicroGenDX. Join Rick and his special guest, the esteemed Caroline Fife, MD, FAAFP, CWS, Professor of Medicine at Baylor College of Medicine, and an expert in wound care and treatment education for chronic wounds. Dr. Fife, also the editor of the influential Wound Care Practice, 2nd Edition, discusses the intersection of microbiology and medicine.” -MicroGenDX

More News & Updates

Stay Up-To-Date With
Venture Medical

Aug 21, 2025

Avoiding wound care for free, a.k.a. surviving a “bad faith” audit.

Audits are meant to protect against fraud, but in wound care many providers are now facing aggressive “bad faith” audits driven by financial incentives and bias. This blog explores what’s behind the rise in these audits, their impact on patients and practitioners, and the steps providers can take to prepare, push back, and protect their practices.

Aug 15, 2025

The price patients will pay for the PFS

After a recent survey we conducted, it is clear most clinicians agreed skin substitutes are highly effective and essential, warning that the proposed rates would reduce patient access, hinder innovation, and threaten the viability of many practices. Read the blog to learn more about our findings.

Aug 11, 2025

Skin Substitutes: An Inconvenient Truth

Proposed Medicare Cuts To Skin Substitutes Could Force Wound Care Clinicians Out, Putting Thousands of Patients at Risk.

Aug 4, 2025

The Case For Mobile Wound Care: An Essential Component Of Chronic Wound Management

Mobile wound care is a critical yet often misunderstood part of chronic wound management, providing advanced treatment to patients who can't easily access traditional care. Far from being a fringe service, it’s a large and growing field—with nearly 30,000 clinicians billing for mobile wound services in 2023 alone—and plays a key role in addressing the rising burden of chronic wounds, especially in nursing homes. As wound severity increases, staffing shortages persist, and the population ages, mobile providers are filling care gaps through high-volume, high-quality services and innovative tools like AI-assisted telehealth and near-infrared spectroscopy. To ensure better outcomes and lower healthcare costs, policymakers and payers must recognize mobile wound care as an essential, professional solution—not a peripheral one.

Jul 30, 2025
John Schroeder
John Schroeder

Venture Position on CMS and MAC Skin Substitute Proposals

Venture Medical, LCC is sharing our position on the CY2026 Medicare Physician Fee Schedule and our future recommendations.

Jul 23, 2025
John Schroeder & Howard Walthall
John Schroeder & Howard Walthall

How CMS Fudged the Math:

If we want reimbursement systems that reflect real-world care and outcomes, we need to speak up. The comment period is now open. Read the full breakdown from John Schroeder and Howard Walthall to learn more about how you can join the call for fair, evidence-based reimbursement.

Jul 11, 2025

The 2026 OPPS and PFS Rules: A Defining Moment for CAMPS Payment Reform

Venture Medical, a leader in wound care solutions, stands at the forefront of advocating for patient access and innovation in response to the 2026 Hospital Outpatient Prospective Payment System (OPPS) proposed rule.

Jul 7, 2025
Michael Schroeder
Michael Schroeder

Venture Medical Leads Investment in Plasmacure to Advance Breakthrough Cold Plasma Technology for Chronic Wound Healing

Venture Medical announces the closing of a strategic investment in Plasmacure B.V., the Dutch MedTech innovator behind PLASOMA, an award-winning cold plasma therapy for complex wound healing.

Jun 12, 2025
John Schroeder
John Schroeder

Venture Medical Announces Acquisition of Select ProgenaCare Global Assets to Expand Advanced Wound Care Portfolio

Venture Medical Announces Acquisition of Select ProgenaCare Global Assets to Expand Advanced Wound Care Portfolio

May 1, 2025

Venture Medical Announces Strategic Partnership with Plasmacure to Bring Groundbreaking Cold Plasma Therapy for Chronic Wounds to the U.S. Market